RaySearch Laboratories

240 articles about RaySearch Laboratories

• Invitation to Extraordinary General Meeting 2022

  10/11/2022

  The Board of Directors has decided that the General Meeting is to be held only through postal voting in accordance with temporary legislation applicable since March 1, 2022.

• Instituto Europeo di Oncologia in Milan in Italy selects RayStation and RayCare for their proton center

  9/23/2022

  RaySearch Laboratories AB announces that Instituto Europeo di Oncologia in Milan has placed an order for RayStation®* treatment planning system and the oncology information system RayCare®*, to be used for radiation treatment with protons.

• Sunnybrook Health Sciences Centre in Canada selects RayStation: RaySearch Laboratories

  9/7/2022

  Sunnybrook Health Sciences Centre, one of Canada's largest hospitals, offers a highly specialized comprehensive cancer program and treats more than 7,000 cancer patients per year.

• RaySearch and Leo Cancer Care join forces to enable upright radiotherapy

  9/2/2022

  A key milestone and partnership for the clinical implementation of upright radiotherapy has been announced.

• RaySearch Laboratories: Interim report April 1 - June 30, 2022

  8/29/2022

  RaySearch signed an agreement with Region Västerbotten to provide RayStation to Norrlands universitetssjukhus.

• RaySearch postpones the publication of the company's interim report for January - June 2022

  8/24/2022

  RaySearch has decided to postpone the publication of the company's interim report for January 1 - June 30, 2022 to August 29, 2022.

• Harris Health System selects RayStation: RaySearch Laboratories

  7/6/2022

  RaySearch Laboratories AB (publ) announces that Harris Health System in Texas, USA , has placed an order for the treatment planning system RayStation®* for its Smith Clinic location.

• Seoul National University Hospital selects RayCare: RaySearch Laboratories

  7/1/2022

  RaySearch Laboratories AB announces that Seoul National University Hospital in South Korea has placed an order for the information oncology system RayCare®*.

• Norrlands universitetssjukhus selects RayStation

  6/30/2022

  RaySearch Laboratories AB announces that Region Västerbotten has placed an order for the treatment planning system RayStation®* to be used at the department for radiotherapy at Norrlands universitetssjukhus.

• RaySearch to exhibit the latest software innovations for particle therapy at PTCOG 2022

  6/27/2022

  RaySearch Laboratories AB (publ) will exhibit at PTCOG 60, to be held in Miami, Florida , USA, during June 27-July 1.

• RaySearch releases RayCare 6A

  6/23/2022

  RaySearch Laboratories AB announces the release of the latest version of RayCare®*, the next generation oncology information system.

• RaySearch Laboratories: Bulletin from the Annual General Meeting 2022

  5/25/2022

  The Annual General Meeting 2022 of RaySearch Laboratories AB was held only through postal voting in accordance with temporary legislation.

• Interim report January 1 - March 31, 2022

  5/18/2022

  In the first quarter of 2022, license revenue rose 35 percent and support revenue rose 24 percent. Operating profit amounted to SEK 30 M.

• RaySearch releases preliminary resultat for the first quarter of 2022

  5/13/2022

  RaySearch Laboratories AB releases preliminary figures for the first quarter of 2022. Order intake increases by 88 percent to SEK 273 million, sales increase by 28 percent to SEK 208 million and EBIT amounts to SEK 29 million.

• RaySearch collaborates with GE Healthcare to improve radiation oncology treatment planning

  5/9/2022

  RaySearch Laboratories AB is proud to announce an agreement to collaborate with GE Healthcare, a leading global medical technology, diagnostics, and digital solutions company, to develop a new radiation therapy simulation and treatment planning workflow solution, designed to make use of the latest advancements in treatment planning technology.

• RayCare in clinical use with CyberKnife at Swiss Medical Network in Switzerland

  5/7/2022

  RaySearch Laboratories AB announces that La Clinique Générale-Beaulieu, a part of Swiss Medical Network in Switzerland, is the first center in the world to treat a patient using the Accuray CyberKnife® radiation treatment delivery system with RaySearch treatment planning system RayStation®* and oncology information system RayCare®*.

• Latest innovations from RayStation, RayIntelligence and RayCare to be presented at ESTRO 2022

  5/5/2022

  RaySearch Laboratories AB will be showcasing the latest oncology software innovations at ESTRO 2022, to be held in Copenhagen, May 6-10.

• Invitation to Annual General Meeting 2022

  4/22/2022

  The shareholders in RaySearch Laboratories AB, corporate identity no. 556322-6157, are hereby invited to the Annual General Meeting, to be held on Wednesday, May 25, 2022.

• CFO Torbjörn Wingårdh leaves RaySearch

  4/5/2022

  RaySearch's CFO, Torbjörn Wingårdh, leaves RaySearch effective immediately. The process to recruit a new CFO has been initiated.

• RaySearch Laboratories : Year-end report 2021

  2/23/2022

  During the fourth quarter of 2021, order intake rose 44 percent and net sales 18 percent. Operating loss amounted to SEK -17 M.